HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood.

Abstract
Acyl-CoA:cholesterol acyltransferase 2 (ACAT2) generates cholesterol esters (CE) for packaging into newly synthesized lipoproteins and thus is a major determinant of blood cholesterol levels. ACAT2 is expressed exclusively in the small intestine and liver, but the relative contributions of ACAT2 expression in these tissues to systemic cholesterol metabolism is unknown. We investigated whether CE derived from the intestine or liver would differentially affect hepatic and plasma cholesterol homeostasis. We generated liver-specific (ACAT2(L-/L-)) and intestine-specific (ACAT2(SI-/SI-)) ACAT2 knockout mice and studied dietary cholesterol-induced hepatic lipid accumulation and hypercholesterolemia. ACAT2(SI-/SI-) mice, in contrast to ACAT2(L-/L-) mice, had blunted cholesterol absorption. However, specific deletion of ACAT2 in the intestine generated essentially a phenocopy of the conditional knockout of ACAT2 in the liver, with reduced levels of plasma very low-density lipoprotein and hepatic CE, yet hepatic-free cholesterol does not build up after high cholesterol intake. ACAT2(L-/L-) and ACAT2(SI-/SI-) mice were equally protected from diet-induced hepatic CE accumulation and hypercholesterolemia. These results suggest that inhibition of intestinal or hepatic ACAT2 improves atherogenic hyperlipidemia and limits hepatic CE accumulation in mice and that depletion of intestinal ACAT2 is sufficient for most of the beneficial effects on cholesterol metabolism. Inhibitors of ACAT2 targeting either tissue likely would be beneficial for atheroprotection.
AuthorsJun Zhang, Kathryn L Kelley, Stephanie M Marshall, Matthew A Davis, Martha D Wilson, Janet K Sawyer, Robert V Farese Jr, J Mark Brown, Lawrence L Rudel
JournalJournal of lipid research (J Lipid Res) Vol. 53 Issue 6 Pg. 1144-52 (Jun 2012) ISSN: 1539-7262 [Electronic] United States
PMID22460046 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol Esters
  • Cholesterol
  • Sterol O-Acyltransferase
Topics
  • Alleles
  • Animals
  • Biliary Tract (metabolism)
  • Cholesterol (blood, metabolism)
  • Cholesterol Esters (metabolism)
  • Diet (adverse effects)
  • Female
  • Gene Knockout Techniques
  • Hypercholesterolemia (etiology, metabolism, prevention & control)
  • Intestinal Absorption
  • Intestinal Mucosa (metabolism)
  • Intestine, Small (metabolism)
  • Liver (metabolism)
  • Mice
  • Organ Specificity
  • Sterol O-Acyltransferase (deficiency, genetics)
  • Sterol O-Acyltransferase 2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: